Blacher S - Search Results

1

Expression of MT4-MMP, EGFR, and RB in Triple-Negative Breast Cancer Strongly Sensitizes Tumors to Erlotinib and Palbociclib Combination Therapy.

Foidart P, Yip C, Radermacher J, Blacher S, Lienard M, Montero-Ruiz L, Maquoi E, Montaudon E, Château-Joubert S, Collignon J, Coibion M, Jossa V, Marangoni E, Noël A, Sounni NE, Jerusalem G. Foidart P, et al. Among authors: blacher s. Clin Cancer Res. 2019 Mar 15;25(6):1838-1850. doi: 10.1158/1078-0432.CCR-18-1880. Epub 2018 Nov 30. Clin Cancer Res. 2019. PMID: 30504427

2

The antitumoral effect of endostatin and angiostatin is associated with a down-regulation of vascular endothelial growth factor expression in tumor cells.

Hajitou A, Grignet C, Devy L, Berndt S, Blacher S, Deroanne CF, Bajou K, Fong T, Chiang Y, Foidart JM, Noël A. Hajitou A, et al. Among authors: blacher s. FASEB J. 2002 Nov;16(13):1802-4. doi: 10.1096/fj.02-0109fje. Epub 2002 Sep 19. FASEB J. 2002. PMID: 12354694

3

Restricted expression of membrane type 1-matrix metalloproteinase by myofibroblasts adjacent to human breast cancer cells.

Bisson C, Blacher S, Polette M, Blanc JF, Kebers F, Desreux J, Tetu B, Rosenbaum J, Foidart JM, Birembaut P, Noel A. Bisson C, et al. Among authors: blacher s. Int J Cancer. 2003 May 20;105(1):7-13. doi: 10.1002/ijc.11012. Int J Cancer. 2003. PMID: 12672023 Free article.

4

Plasmin-activated doxorubicin prodrugs containing a spacer reduce tumor growth and angiogenesis without systemic toxicity.

Devy L, de Groot FM, Blacher S, Hajitou A, Beusker PH, Scheeren HW, Foidart JM, Noël A. Devy L, et al. Among authors: blacher s. FASEB J. 2004 Mar;18(3):565-7. doi: 10.1096/fj.03-0462fje. Epub 2004 Jan 20. FASEB J. 2004. PMID: 14734647

5

Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytes.

Masson V, de la Ballina LR, Munaut C, Wielockx B, Jost M, Maillard C, Blacher S, Bajou K, Itoh T, Itohara S, Werb Z, Libert C, Foidart JM, Noël A. Masson V, et al. Among authors: blacher s. FASEB J. 2005 Feb;19(2):234-6. doi: 10.1096/fj.04-2140fje. Epub 2004 Nov 18. FASEB J. 2005. PMID: 15550552 Free PMC article.

6

Membrane-type 4 matrix metalloproteinase promotes breast cancer growth and metastases.

Chabottaux V, Sounni NE, Pennington CJ, English WR, van den Brûle F, Blacher S, Gilles C, Munaut C, Maquoi E, Lopez-Otin C, Murphy G, Edwards DR, Foidart JM, Noël A. Chabottaux V, et al. Among authors: blacher s. Cancer Res. 2006 May 15;66(10):5165-72. doi: 10.1158/0008-5472.CAN-05-3012. Cancer Res. 2006. PMID: 16707440 Free article.

7

Earlier onset of tumoral angiogenesis in matrix metalloproteinase-19-deficient mice.

Jost M, Folgueras AR, Frérart F, Pendas AM, Blacher S, Houard X, Berndt S, Munaut C, Cataldo D, Alvarez J, Melen-Lamalle L, Foidart JM, López-Otín C, Noël A. Jost M, et al. Among authors: blacher s. Cancer Res. 2006 May 15;66(10):5234-41. doi: 10.1158/0008-5472.CAN-05-4315. Cancer Res. 2006. PMID: 16707448 Free article.

8

Inhibition of tumor growth and metastasis establishment by adenovirus-mediated gene transfer delivery of the antiangiogenic factor 16K hPRL.

Nguyen NQ, Cornet A, Blacher S, Tabruyn SP, Foidart JM, Noël A, Martial JA, Struman I. Nguyen NQ, et al. Among authors: blacher s. Mol Ther. 2007 Dec;15(12):2094-100. doi: 10.1038/sj.mt.6300294. Epub 2007 Aug 28. Mol Ther. 2007. PMID: 17726458 Free article.

9

6-Substituted 2-oxo-2H-1-benzopyran-3-carboxylic acid derivatives in a new approach of the treatment of cancer cell invasion and metastasis.

Kempen I, Hemmer M, Counerotte S, Pochet L, de Tullio P, Foidart JM, Blacher S, Noël A, Frankenne F, Pirotte B. Kempen I, et al. Among authors: blacher s. Eur J Med Chem. 2008 Dec;43(12):2735-50. doi: 10.1016/j.ejmech.2008.01.024. Epub 2008 Jan 31. Eur J Med Chem. 2008. PMID: 18329754 Free article.

10

Membrane-type 4 matrix metalloproteinase (MT4-MMP) induces lung metastasis by alteration of primary breast tumour vascular architecture.

Chabottaux V, Ricaud S, Host L, Blacher S, Paye A, Thiry M, Garofalakis A, Pestourie C, Gombert K, Bruyere F, Lewandowsky D, Tavitian B, Foidart JM, Duconge F, Noel A. Chabottaux V, et al. Among authors: blacher s. J Cell Mol Med. 2009 Sep;13(9B):4002-13. doi: 10.1111/j.1582-4934.2009.00764.x. Epub 2009 May 10. J Cell Mol Med. 2009. PMID: 19426156 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

133 results

Search Page